Breaking AI & Tech News Analyzed

The Rock and Roll Hall of Fame has revealed its list of 2026 inductees, showcasing a diverse range of artists who have made significant contributions to the music industry. Phil Collins, known for hits like 'In the Air Tonight' and 'One More Night', will be inducted, despite already being part of the hall as a member of Genesis. Collins has earned eight Grammys, including album of the year in 1985 for 'No Jacket Required'.Oasis, the iconic Britpop band, will also be inducted, marking a significant recognition of their impact on the music scene. Sade, the soul-jazz vocalist, is another notable inductee, known for songs like 'Smooth Operator' and 'The Sweetest Taboo'. This will be her second nomination, following her first in 2024.The Wu-Tang Clan will be recognized as rap innovators, having released their game-changing debut album 'Enter the Wu-Tang (36 Chambers)' in 1993. Other inductees include Iron Maiden, who helped power the new wave of British heavy metal, and Luther Vandross, who sold over 25m albums and inspired artists like Kendrick Lamar and SZA.The induction ceremony will take place on November 14 at the Peacock theater in Los Angeles. In addition to the performer category, the Hall of Fame will also celebrate contributions across three special categories: early influence, musical excellence, and the Ahmet Ertegun non-performer award.This year's early influence category will honor Queen Latifah, Celia Cruz, Fela Kuti, MC Lyte, and Gram Parsons. The musical excellence category will recognize songwriter Linda Creed and producers Arif Mardin, Jimmy Miller, and Rick Rubin. The Ahmet Ertegun non-performer award will go to Ed Sullivan, the legendary host of the eponymous TV show that launched many musical icons of the 1950s and 1960s.

The latest offering from writer Theo Jamieson and director Adam Lenson is a boldly conceived musical that thrusts a turbulent romance into a sci‑fi framework. The story follows a young astronaut, Daniel, who vanishes from his shuttle with barely enough fuel, prompting a quest to uncover the motives behind his reckless flight.Stuart Thompson (as Daniel) and Poppy Gilbert (as Emily) anchor the piece with performances that are both visceral and nuanced. Their chemistry captures the push‑pull of a relationship scarred by childhood bullying, parental betrayal, and a shared history of trauma, delivering songs that soar and hit hard.Visually, the production leans heavily on interstellar projections that transform the stage into a shifting cosmos, while the score oscillates between Sondheim‑style wit and full‑blown symphonic passages. This combination creates an epic sense of strangeness that distinguishes Flyby from more conventional West End fare.However, the narrative’s fragmented structure hampers its emotional payoff. The non‑chronological storytelling leaves critical gaps, and the metaphor of being "stranded in space" feels over‑extended—especially with the protagonist’s surname, Defoe, a thin nod to Robinson Crusoe. The three narrators, played by Simbi Akande, Gina Beck, and Rupert Young, often drift into digressive asides that dilute the central arc.Despite these flaws, moments of brilliance emerge, particularly in the musical’s treatment of mental‑health themes. The show hints at the potential to join the ranks of modern theatre successes like Next to Normal and Dear Evan Hansen, should its structural rough edges be smoothed.The production is currently staged at Southwark Playhouse, Borough, London and will run through 16 May. Audiences seeking a daring blend of emotional intensity and cosmic spectacle will find Flyby a compelling, if imperfect, experience.

Researchers have made a significant breakthrough in understanding why weight-loss medications, such as GLP1 receptor agonists, work better for some individuals than others. A recent study published in Nature has identified genetic variations in two genes involved in gut hormone pathways that regulate appetite and digestion. These genetic variations may help account for different weight-loss results or side-effects when taking glucagon-like peptide 1 (GLP1) medicines, which mimic natural gut hormones to regulate appetite, insulin release, and digestion. The study analyzed data from 27,885 patients on GLP1 drugs and found that specific genetic variants were associated with slightly more weight loss or side-effects like nausea and vomiting. The findings suggest that genetic differences may contribute to why people respond differently to weight-loss jabs. However, the overall impact of genetics appeared to be modest, with non-genetic factors such as sex, drug type, dose, and duration appearing to explain a substantially larger proportion of variability. The study's results reinforce that while there is substantial variability in response to GLP1 therapies, genetics is only one part of a much more complex picture. According to Marie Spreckley, an obesity expert at the University of Cambridge, the study provides plausible evidence that genetic variants could affect outcomes. However, she notes that the magnitude of these genetic effects is small in clinical terms, and that behavioral, clinical, and treatment-related factors remain the dominant drivers of outcomes. The study's authors suggest that their findings could support future efforts to use genetic information when making treatment choices for obesity. However, Spreckley cautions that the evidence is not yet sufficient to support using genetic information to guide treatment decisions in routine clinical practice.

János Bődey's photograph of two elderly ladies dressed as bride and groom in a Hungarian retirement home has captured the essence of joy and love in old age. The image is part of his series Carnival at the Retirement Home, which showcases the fulfilling lives of pensioners who have overcome difficulties.In Hungary, the average pension is approximately £500 a month, making it challenging for retirees to afford leisure, culture, or travel. Additionally, the health of Hungarian pensioners often falls short of Western standards, and securing a spot in a retirement home can be a lengthy process.Bődey's subjects, Magdolna, 87, and Irén, 86, have lived with their husbands for over 50 and 62 years, respectively, until their spouses passed away. They attribute their long and happy lives to a combination of good genes, an active lifestyle, and a healthy marriage.The photographer's series aims to serve as a role model for both peers and the middle generation, demonstrating that it's possible to lead a fulfilling life in old age. The elderly ladies recommend a healthy, active life with plenty of walking and traveling, as well as avoiding debt.Bődey's work is a departure from his usual coverage of conflicts and social issues. He finds inspiration in the happiness and playfulness of the carnival celebrations, which begin in February to mark the end of winter.The photographer's experience has taught him the importance of preparing for retirement by gathering emotional and financial resources, setting goals, and being creative. His series has been shortlisted for the Sony World Photography Awards 2026 and will be exhibited at Somerset House in London from April 17 to May 4.

Caster Semenya, the two‑time Olympic 800‑metre champion, has pledged to fight the International Olympic Committee’s (IOC) newly announced gender‑testing policy that would apply to all female athletes competing in strength, power or endurance events. The South African athlete says the rule "undermines women’s rights" and lacks scientific justification. The IOC unveiled the policy last week, stating that including “androgen‑sensitive XY‑DSD athletes” in the female category "runs fundamentally counter to ensuring fairness, safety and integrity in elite competition." The measure is expected to become a universal requirement across Olympic sports, replacing a patchwork of national regulations that have sparked controversy for years. Semanya, who has been embroiled in a long‑running legal dispute with World Athletics over her right to compete despite having a Difference of Sexual Development (DSD), told Reuters, "We’re going to be vocal about it, we’re going to make noise until we’re heard". She added, "Enough is enough – women will not be told how to compete". DSDs are rare conditions involving variations in genes, hormones and reproductive anatomy. Some individuals with DSDs are raised as female yet possess XY chromosomes and testosterone levels typical of males. The IOC’s testing protocol will involve a cheek‑swab or saliva sample to detect the SRY gene on the Y chromosome, with further investigation for any positive results. Semanya rejected the scientific premise of the rule, stating, "There’s no science that XY‑DSD gives an athlete an advantage". She emphasized that athletic success stems from hard work, not genetics, and criticized those who claim intersex conditions confer a performance edge. She also criticized IOC President Kirsty Coventry, the first woman and first African to hold the position, for failing to consult athletes with DSDs before issuing the policy. "They sent us a letter the day they were going to publish the new policy," Semanya said, urging genuine stakeholder engagement rather than a perfunctory "tick‑the‑box" approach. By labeling the policy as a breach of women’s dignity and rights, Semanya aims to rally broader support for intersex athletes and challenge what she describes as a historically flawed testing regime.